Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease

P. Dongiovanni, L. Valenti, R. Rametta, A. K. Daly, V. Nobili, E. Mozzi, J. B S Leathart, A. Pietrobattista, A. D. Burt, M. Maggioni, A. L. Fracanzani, E. Lattuada, M. A. Zappa, G. Roviaro, G. Marchesini, C. P. Day, S. Fargion

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Background/aims: The aim of this study was to assess the effect of functional ENPP1(ectoenzyme nucleotide pyrophosphate phosphodiesterase 1)/PC-1 (plasma cell antigen-1) and IRS-1 (insulin receptor substrate-1) polymorphisms influencing insulin receptor activity on liver damage in non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, whose progression is associated with the severity of insulin resistance. Patients and methods: 702 patients with biopsy-proven NAFLD from Italy and the UK, and 310 healthy controls. The Lys121Gln ENPP1/PC-1 and the Gly972Arg IRS-1 polymorphisms were evaluated by restriction analysis. Fibrosis was evaluated according to Kleiner. Insulin signalling activity was evaluated by measuring phosphoAKT levels by western blotting in a subset of obese non-diabetic patients. Results: The ENPP1 121Gln and IRS-1 972Arg polymorphisms were detected in 28.7% and 18.1% of patients and associated with increased body weight/dyslipidaemia and diabetes risk, respectively. The ENPP1 121Gln allele was significantly associated with increased prevalence of fibrosis stage >1 and

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalGut
Volume59
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Insulin Receptor
Phosphoric Diester Hydrolases
Insulin Receptor Substrate Proteins
Nucleotides
Liver
Fibrosis
Antigen Receptors
Dyslipidemias
Plasma Cells
Italy
Insulin Resistance
Western Blotting
Alleles
Body Weight
Insulin
Biopsy
Non-alcoholic Fatty Liver Disease
diphosphoric acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. / Dongiovanni, P.; Valenti, L.; Rametta, R.; Daly, A. K.; Nobili, V.; Mozzi, E.; Leathart, J. B S; Pietrobattista, A.; Burt, A. D.; Maggioni, M.; Fracanzani, A. L.; Lattuada, E.; Zappa, M. A.; Roviaro, G.; Marchesini, G.; Day, C. P.; Fargion, S.

In: Gut, Vol. 59, No. 2, 02.2010, p. 267-273.

Research output: Contribution to journalArticle

Dongiovanni, P. ; Valenti, L. ; Rametta, R. ; Daly, A. K. ; Nobili, V. ; Mozzi, E. ; Leathart, J. B S ; Pietrobattista, A. ; Burt, A. D. ; Maggioni, M. ; Fracanzani, A. L. ; Lattuada, E. ; Zappa, M. A. ; Roviaro, G. ; Marchesini, G. ; Day, C. P. ; Fargion, S. / Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. In: Gut. 2010 ; Vol. 59, No. 2. pp. 267-273.
@article{7dfcada1bf2e4cf78e7c23ae9eb5e417,
title = "Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease",
abstract = "Background/aims: The aim of this study was to assess the effect of functional ENPP1(ectoenzyme nucleotide pyrophosphate phosphodiesterase 1)/PC-1 (plasma cell antigen-1) and IRS-1 (insulin receptor substrate-1) polymorphisms influencing insulin receptor activity on liver damage in non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, whose progression is associated with the severity of insulin resistance. Patients and methods: 702 patients with biopsy-proven NAFLD from Italy and the UK, and 310 healthy controls. The Lys121Gln ENPP1/PC-1 and the Gly972Arg IRS-1 polymorphisms were evaluated by restriction analysis. Fibrosis was evaluated according to Kleiner. Insulin signalling activity was evaluated by measuring phosphoAKT levels by western blotting in a subset of obese non-diabetic patients. Results: The ENPP1 121Gln and IRS-1 972Arg polymorphisms were detected in 28.7{\%} and 18.1{\%} of patients and associated with increased body weight/dyslipidaemia and diabetes risk, respectively. The ENPP1 121Gln allele was significantly associated with increased prevalence of fibrosis stage >1 and",
author = "P. Dongiovanni and L. Valenti and R. Rametta and Daly, {A. K.} and V. Nobili and E. Mozzi and Leathart, {J. B S} and A. Pietrobattista and Burt, {A. D.} and M. Maggioni and Fracanzani, {A. L.} and E. Lattuada and Zappa, {M. A.} and G. Roviaro and G. Marchesini and Day, {C. P.} and S. Fargion",
year = "2010",
month = "2",
doi = "10.1136/gut.2009.190801",
language = "English",
volume = "59",
pages = "267--273",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease

AU - Dongiovanni, P.

AU - Valenti, L.

AU - Rametta, R.

AU - Daly, A. K.

AU - Nobili, V.

AU - Mozzi, E.

AU - Leathart, J. B S

AU - Pietrobattista, A.

AU - Burt, A. D.

AU - Maggioni, M.

AU - Fracanzani, A. L.

AU - Lattuada, E.

AU - Zappa, M. A.

AU - Roviaro, G.

AU - Marchesini, G.

AU - Day, C. P.

AU - Fargion, S.

PY - 2010/2

Y1 - 2010/2

N2 - Background/aims: The aim of this study was to assess the effect of functional ENPP1(ectoenzyme nucleotide pyrophosphate phosphodiesterase 1)/PC-1 (plasma cell antigen-1) and IRS-1 (insulin receptor substrate-1) polymorphisms influencing insulin receptor activity on liver damage in non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, whose progression is associated with the severity of insulin resistance. Patients and methods: 702 patients with biopsy-proven NAFLD from Italy and the UK, and 310 healthy controls. The Lys121Gln ENPP1/PC-1 and the Gly972Arg IRS-1 polymorphisms were evaluated by restriction analysis. Fibrosis was evaluated according to Kleiner. Insulin signalling activity was evaluated by measuring phosphoAKT levels by western blotting in a subset of obese non-diabetic patients. Results: The ENPP1 121Gln and IRS-1 972Arg polymorphisms were detected in 28.7% and 18.1% of patients and associated with increased body weight/dyslipidaemia and diabetes risk, respectively. The ENPP1 121Gln allele was significantly associated with increased prevalence of fibrosis stage >1 and

AB - Background/aims: The aim of this study was to assess the effect of functional ENPP1(ectoenzyme nucleotide pyrophosphate phosphodiesterase 1)/PC-1 (plasma cell antigen-1) and IRS-1 (insulin receptor substrate-1) polymorphisms influencing insulin receptor activity on liver damage in non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, whose progression is associated with the severity of insulin resistance. Patients and methods: 702 patients with biopsy-proven NAFLD from Italy and the UK, and 310 healthy controls. The Lys121Gln ENPP1/PC-1 and the Gly972Arg IRS-1 polymorphisms were evaluated by restriction analysis. Fibrosis was evaluated according to Kleiner. Insulin signalling activity was evaluated by measuring phosphoAKT levels by western blotting in a subset of obese non-diabetic patients. Results: The ENPP1 121Gln and IRS-1 972Arg polymorphisms were detected in 28.7% and 18.1% of patients and associated with increased body weight/dyslipidaemia and diabetes risk, respectively. The ENPP1 121Gln allele was significantly associated with increased prevalence of fibrosis stage >1 and

UR - http://www.scopus.com/inward/record.url?scp=77149168465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149168465&partnerID=8YFLogxK

U2 - 10.1136/gut.2009.190801

DO - 10.1136/gut.2009.190801

M3 - Article

VL - 59

SP - 267

EP - 273

JO - Gut

JF - Gut

SN - 0017-5749

IS - 2

ER -